Twist Bioscience Corporation (TWST) Free cash flow 2017–2025
Twist Bioscience Corporation (TWST) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$75.6MFY2025 · since FY2017: -$57.9M → -$75.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$75.6M | -9.3% |
| FY2024 | -$69.2M | +59.4% |
| FY2023 | -$170.3M | +24.7% |
| FY2022 | -$226.2M | -62.4% |
| FY2021 | -$139.3M | +8.4% |
| FY2020 | -$152.1M | -48.1% |
| FY2019 | -$102.7M | -47.0% |
| FY2018 | -$69.9M | -20.7% |
| FY2017 | -$57.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TWST financial trends
TWST RevenueTWST Net incomeTWST Net marginTWST Gross profitTWST Gross marginTWST Operating incomeTWST Operating marginTWST Operating cash flowTWST Capital expendituresTWST Return on equityTWST Stock buybacksTWST Dividends paidTWST Total assetsTWST Total liabilitiesTWST Shareholders’ equityTWST overview →